Oxytocin vs VIP (Vasoactive Intestinal Polypeptide)
Updated August 6, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of Oxytocin and VIP (Vasoactive Intestinal Polypeptide) (also searched as VIP (Vasoactive Intestinal Polypeptide) vs Oxytocin) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
Oxytocin centers on neuro, while VIP (Vasoactive Intestinal Polypeptide) leans toward neuro. On indexed research, Oxytocin is ahead (Oxytocin: 18 studies, Human clinical; VIP (Vasoactive Intestinal Polypeptide): 18, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •Oxytocin is strongest for neuro; VIP (Vasoactive Intestinal Polypeptide) for neuro.
- •Evidence: Oxytocin Human clinical (18 studies) vs VIP (Vasoactive Intestinal Polypeptide) Human clinical (18).
- •Check the FDA-approval status chips above before assuming a legal use pathway.
Effect profiles, overlaid
At a glance
Neuropeptide | Social bonding and emotional regulation
Neuropeptide | Immune modulation
Oxytocin vs VIP (Vasoactive Intestinal Polypeptide): side-by-side
| Metric | Oxytocin | VIP (Vasoactive Intestinal Polypeptide) |
|---|---|---|
| Class | Neuro | Neuro |
| Regulatory status | FDA-approved | Research use only |
| Evidence grade | Human clinical | Human clinical |
| Studies indexed | 18 | 18 |
| Research level | FDA Approved | Well Studied |
| Strongest effect | Neuro & mood | Neuro & mood |
| Healing & recovery | 3.0▲ | 3.0▲ |
| Muscle & body comp | 0.0 | 1.0▲ |
| Metabolic & appetite | 0.0 | 2.0▲ |
| Neuro & mood | 4.0▲ | 4.0▲ |
| Sleep & circadian | 0.0 | 3.0▲ |
| Inflammation & immune | 0.0 | 3.0▲ |
| Skin & aesthetics | 0.0 | 1.0▲ |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | Oxytocin | VIP (Vasoactive Intestinal Polypeptide) |
|---|---|---|
| Mechanism | Oxytocin receptor agonist | VPAC1 and VPAC2 receptor agonist |
| Route | Intravenous injection; Intranasal administration | — |
| Half-life | ~3–5 min | — |
| Time to peak | 30–120 min | — |
| Duration of action | 1–2 hours | — |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is Oxytocin?
Oxytocin is a neuropeptide that plays a crucial role in social bonding, reproductive behaviors, and emotional regulation. Its functions extend to various physiological processes, including childbirth and lactation, and it has garnered interest for its potential therapeutic applications in mental health and social disorders.
Full Oxytocin profile, mechanism & studies →What is VIP (Vasoactive Intestinal Polypeptide)?
Vasoactive Intestinal Peptide | Neuropeptide
Full VIP (Vasoactive Intestinal Polypeptide) profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Even | Both ~3.0/5 |
| Muscle | VIP (Vasoactive Intestinal Polypeptide) | 1.0/5 effect signal |
| Metabolic | VIP (Vasoactive Intestinal Polypeptide) | 2.0/5 effect signal |
| Neuro | Even | Both ~4.0/5 |
| Sleep | VIP (Vasoactive Intestinal Polypeptide) | 3.0/5 effect signal |
| Inflammation | VIP (Vasoactive Intestinal Polypeptide) | 3.0/5 effect signal |
| Skin | VIP (Vasoactive Intestinal Polypeptide) | 1.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack Oxytocin and VIP (Vasoactive Intestinal Polypeptide)?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because at least one is a research-use compound, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
Oxytocin vs VIP (Vasoactive Intestinal Polypeptide): side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
Oxytocin has 18 approved studies indexed (Human clinical), and VIP (Vasoactive Intestinal Polypeptide) has 18 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is Oxytocin or VIP (Vasoactive Intestinal Polypeptide) better?
It depends on your goal. Oxytocin is strongest for neuro; VIP (Vasoactive Intestinal Polypeptide) for neuro. Oxytocin has more indexed studies (18). See the goal-by-goal breakdown above.
Is Oxytocin or VIP (Vasoactive Intestinal Polypeptide) better for weight loss?
VIP (Vasoactive Intestinal Polypeptide) shows the stronger metabolic & appetite profile (2.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.
Is Oxytocin or VIP (Vasoactive Intestinal Polypeptide) better for muscle?
VIP (Vasoactive Intestinal Polypeptide) leads on the muscle & body-composition axis (1.0/5).
Which has more research, Oxytocin or VIP (Vasoactive Intestinal Polypeptide)?
Oxytocin has 18 approved studies indexed (Human clinical); VIP (Vasoactive Intestinal Polypeptide) has 18 (Human clinical). Higher counts mean more to read, not proven superiority.
Can you stack Oxytocin and VIP (Vasoactive Intestinal Polypeptide)?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of Oxytocin vs VIP (Vasoactive Intestinal Polypeptide)?
Oxytocin: no community-reported effects logged yet. VIP (Vasoactive Intestinal Polypeptide): none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is Oxytocin or VIP (Vasoactive Intestinal Polypeptide) FDA-approved?
Oxytocin is FDA-approved. VIP (Vasoactive Intestinal Polypeptide) is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is VIP (Vasoactive Intestinal Polypeptide) better than Oxytocin?
For neuro, VIP (Vasoactive Intestinal Polypeptide) has the edge; for neuro, Oxytocin does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Approval status varies (see the chips at the top). FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed August 6, 2026.